{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T01:28:24Z","timestamp":1793842104789,"version":"4.6.1"},"reference-count":127,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R35GM142937"],"award-info":[{"award-number":["R35GM142937"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK132361"],"award-info":[{"award-number":["R01DK132361"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Engineering\u2013Dentistry Interdisciplinary Research Grant"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Insulin receptor (IR) signaling has traditionally been viewed as a canonical pathway in which insulin binding uniformly activates downstream metabolic and mitogenic responses. However, growing evidence indicates that IR signaling is not monolithic. Instead, IR signaling is increasingly recognized as a context-dependent process in which receptor conformation, spatial organization, and intracellular trafficking shape signaling outcomes. These non-canonical regulatory mechanisms generate distinct signaling states that can differentially regulate metabolic, mitogenic, immune, and neuronal functions. Recent advances in engineered insulin mimetics, including peptides, antibodies, aptamers, and de novo designed ligands, have provided powerful tools to probe this signaling diversity. By stabilizing specific receptor conformations or engagement geometries, these ligands can selectively bias downstream signaling programs. Here we discuss recent insights into how the qualitative features of IR signaling, rather than signaling amplitude alone, determine disease outcomes across diverse pathological contexts. Understanding this signaling diversity may enable the rational design of next-generation insulin mimetics and more precise therapeutic strategies targeting IR pathways.<\/jats:p>","DOI":"10.1038\/s12276-026-01862-5","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:16:30Z","timestamp":1791357390000},"page":"3288-3300","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Insulin mimetics and non-canonical insulin receptor signaling: mechanisms and disease relevance"],"prefix":"10.1038","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6146-6213","authenticated-orcid":false,"given":"Junhee","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3286-6477","authenticated-orcid":false,"given":"Eunhee","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,7]]},"reference":[{"key":"1862_CR1","first-page":"251","volume":"125","author":"FG Banting","year":"2007","unstructured":"Banting, F. G. & Best, C. H. The internal secretion of the pancreas. 1922. Indian J. Med Res 125, 251\u2013266 (2007).","journal-title":"Indian J. Med Res"},{"key":"1862_CR2","first-page":"141","volume":"12","author":"FG Banting","year":"1922","unstructured":"Banting, F. G., Best, C. H., Collip, J. B., Campbell, W. R. & Fletcher, A. A. Pancreatic extracts in the treatment of diabetes mellitus. Can. Med Assoc. J. 12, 141\u2013146 (1922).","journal-title":"Can. Med Assoc. J."},{"key":"1862_CR3","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/0006-291x(71)90604-8","volume":"44","author":"P Cuatrecasas","year":"1971","unstructured":"Cuatrecasas, P., Desbuquois, B. & Krug, F. Insulin-receptor interactions in liver cell membranes. Biochem Biophys. Res Commun. 44, 333\u2013339 https:\/\/doi.org\/10.1016\/0006-291x(71)90604-8 (1971).","journal-title":"Biochem Biophys. Res Commun."},{"key":"1862_CR4","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/0092-8674(85)90334-4","volume":"40","author":"Y Ebina","year":"1985","unstructured":"Ebina, Y. et al. The human insulin receptor cDNA: the structural basis for hormone-activated transmembrane signalling. Cell 40, 747\u2013758 https:\/\/doi.org\/10.1016\/0092-8674(85)90334-4 (1985).","journal-title":"Cell"},{"key":"1862_CR5","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1126\/science.7031900","volume":"215","author":"M Kasuga","year":"1982","unstructured":"Kasuga, M., Karlsson, F. A. & Kahn, C. R. Insulin stimulates the phosphorylation of the 95,000-dalton subunit of its own receptor. Science 215, 185\u2013187 https:\/\/doi.org\/10.1126\/science.7031900 (1982).","journal-title":"Science"},{"key":"1862_CR6","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a009191","volume":"6","author":"J Boucher","year":"2014","unstructured":"Boucher, J., Kleinridders, A. & Kahn, C. R. Insulin receptor signaling in normal and insulin-resistant states. Cold Spring Harb. Perspect. Biol. 6, a009191 https:\/\/doi.org\/10.1101\/cshperspect.a009191 (2014).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"1862_CR7","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1111\/cns.12866","volume":"24","author":"I Pomytkin","year":"2018","unstructured":"Pomytkin, I. et al. Insulin receptor in the brain: mechanisms of activation and the role in the CNS pathology and treatment. CNS Neurosci. Ther. 24, 763\u2013774 https:\/\/doi.org\/10.1111\/cns.12866 (2018).","journal-title":"CNS Neurosci. Ther."},{"key":"1862_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1128622","volume":"14","author":"P Makhijani","year":"2023","unstructured":"Makhijani, P. et al. Regulation of the immune system by the insulin receptor in health and disease. Front Endocrinol. (Lausanne) 14, 1128622 https:\/\/doi.org\/10.3389\/fendo.2023.1128622 (2023).","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"1862_CR9","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1042\/CS20120378","volume":"124","author":"LJ Hale","year":"2013","unstructured":"Hale, L. J. & Coward, R. J. Insulin signalling to the kidney in health and disease. Clin. Sci. (Lond.) 124, 351\u2013370 https:\/\/doi.org\/10.1042\/CS20120378 (2013).","journal-title":"Clin. Sci. (Lond.)"},{"key":"1862_CR10","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s41568-020-0295-5","volume":"20","author":"EJ Gallagher","year":"2020","unstructured":"Gallagher, E. J. & LeRoith, D. Hyperinsulinaemia in cancer. Nat. Rev. Cancer 20, 629\u2013644 https:\/\/doi.org\/10.1038\/s41568-020-0295-5 (2020).","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"1862_CR11","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1177\/00220345251366952","volume":"105","author":"Y Sohn","year":"2026","unstructured":"Sohn, Y., Jeong, H.J. & Park, J. The Link between Hyperinsulinemia and Periodontitis in Diabetics. J. Dent. Res 105(3), 294\u2013301 https:\/\/doi.org\/10.1177\/00220345251366952 (2026).","journal-title":"J. Dent. Res"},{"key":"1862_CR12","doi-asserted-by":"publisher","first-page":"F1087","DOI":"10.1152\/ajprenal.00340.2016","volume":"311","author":"B Spoto","year":"2016","unstructured":"Spoto, B., Pisano, A. & Zoccali, C. Insulin resistance in chronic kidney disease: a systematic review. Am. J. Physiol. Ren. Physiol. 311, F1087\u2013F1108 https:\/\/doi.org\/10.1152\/ajprenal.00340.2016 (2016).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"1862_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35176-7","volume":"13","author":"A Dall\u2019Agnese","year":"2022","unstructured":"Dall\u2019Agnese, A. et al. The dynamic clustering of insulin receptor underlies its signaling and is disrupted in insulin resistance. Nat. Commun. 13, 7522 https:\/\/doi.org\/10.1038\/s41467-022-35176-7 (2022).","journal-title":"Nat. Commun."},{"key":"1862_CR14","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1038\/s12276-020-0456-3","volume":"52","author":"C Hall","year":"2020","unstructured":"Hall, C., Yu, H. & Choi, E. Insulin receptor endocytosis in the pathophysiology of insulin resistance. Exp. Mol. Med 52, 911\u2013920 https:\/\/doi.org\/10.1038\/s12276-020-0456-3 (2020).","journal-title":"Exp. Mol. Med"},{"key":"1862_CR15","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1002\/bies.200800210","volume":"31","author":"CW Ward","year":"2009","unstructured":"Ward, C. W. & Lawrence, M. C. Ligand-induced activation of the insulin receptor: a multi-step process involving structural changes in both the ligand and the receptor. Bioessays 31, 422\u2013434 https:\/\/doi.org\/10.1002\/bies.200800210 (2009).","journal-title":"Bioessays"},{"key":"1862_CR16","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.str.2015.12.014","volume":"24","author":"TI Croll","year":"2016","unstructured":"Croll, T. I. et al. Higher-resolution structure of the human insulin receptor ectodomain: multi-modal inclusion of the insert domain. Structure 24, 469\u2013476 https:\/\/doi.org\/10.1016\/j.str.2015.12.014 (2016).","journal-title":"Structure"},{"key":"1862_CR17","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/nature05106","volume":"443","author":"NM McKern","year":"2006","unstructured":"McKern, N. M. et al. Structure of the insulin receptor ectodomain reveals a folded-over conformation. Nature 443, 218\u2013221 https:\/\/doi.org\/10.1038\/nature05106 (2006).","journal-title":"Nature"},{"key":"1862_CR18","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/nature26153","volume":"556","author":"G Scapin","year":"2018","unstructured":"Scapin, G. et al. Structure of the insulin receptor-insulin complex by single-particle cryo-EM analysis. Nature 556, 122\u2013125 https:\/\/doi.org\/10.1038\/nature26153 (2018).","journal-title":"Nature"},{"key":"1862_CR19","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.48630","volume":"8","author":"E Uchikawa","year":"2019","unstructured":"Uchikawa, E., Choi, E., Shang, G., Yu, H. & Bai, X. C. Activation mechanism of the insulin receptor revealed by cryo-EM structure of the fully liganded receptor-ligand complex. Elife 8, e48630 https:\/\/doi.org\/10.7554\/eLife.48630 (2019).","journal-title":"Elife"},{"key":"1862_CR20","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/nature11781","volume":"493","author":"JG Menting","year":"2013","unstructured":"Menting, J. G. et al. How insulin engages its primary binding site on the insulin receptor. Nature 493, 241\u2013245 https:\/\/doi.org\/10.1038\/nature11781 (2013).","journal-title":"Nature"},{"key":"1862_CR21","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1146\/annurev-biochem-052521-033250","volume":"92","author":"E Choi","year":"2023","unstructured":"Choi, E. & Bai, X. C. The activation mechanism of the insulin receptor: a structural perspective. Annu Rev. Biochem 92, 247\u2013272 https:\/\/doi.org\/10.1146\/annurev-biochem-052521-033250 (2023).","journal-title":"Annu Rev. Biochem"},{"key":"1862_CR22","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/s41580-025-00826-3","volume":"26","author":"E Choi","year":"2025","unstructured":"Choi, E., Duan, C. & Bai, X. C. Regulation and function of insulin and insulin-like growth factor receptor signalling. Nat. Rev. Mol. Cell Biol. 26, 558\u2013580 https:\/\/doi.org\/10.1038\/s41580-025-00826-3 (2025).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1862_CR23","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.1016\/S0021-9258(18)69163-X","volume":"263","author":"MF White","year":"1988","unstructured":"White, M. F., Shoelson, S. E., Keutmann, H. & Kahn, C. R. A cascade of tyrosine autophosphorylation in the beta-subunit activates the phosphotransferase of the insulin receptor. J. Biol. Chem. 263, 2969\u20132980 (1988).","journal-title":"J. Biol. Chem."},{"key":"1862_CR24","doi-asserted-by":"publisher","first-page":"5572","DOI":"10.1093\/emboj\/16.18.5572","volume":"16","author":"SR Hubbard","year":"1997","unstructured":"Hubbard, S. R. Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog. EMBO J. 16, 5572\u20135581 https:\/\/doi.org\/10.1093\/emboj\/16.18.5572 (1997).","journal-title":"EMBO J."},{"key":"1862_CR25","doi-asserted-by":"publisher","first-page":"5326","DOI":"10.1210\/endo.137.12.8940353","volume":"137","author":"AG Danielsen","year":"1996","unstructured":"Danielsen, A. G. & Roth, R. A. Role of the juxtamembrane tyrosine in insulin receptor-mediated tyrosine phosphorylation of p60 endogenous substrates. Endocrinology 137, 5326\u20135331 https:\/\/doi.org\/10.1210\/endo.137.12.8940353 (1996).","journal-title":"Endocrinology"},{"key":"1862_CR26","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/s0092-8674(88)80008-4","volume":"54","author":"MF White","year":"1988","unstructured":"White, M. F. et al. Mutation of the insulin receptor at tyrosine 960 inhibits signal transmission but does not affect its tyrosine kinase activity. Cell 54, 641\u2013649 https:\/\/doi.org\/10.1016\/s0092-8674(88)80008-4 (1988).","journal-title":"Cell"},{"key":"1862_CR27","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/352073a0","volume":"352","author":"XJ Sun","year":"1991","unstructured":"Sun, X. J. et al. Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature 352, 73\u201377 https:\/\/doi.org\/10.1038\/352073a0 (1991).","journal-title":"Nature"},{"key":"1862_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0021-9258(17)42297-6","volume":"269","author":"MF White","year":"1994","unstructured":"White, M. F. & Kahn, C. R. The insulin signaling system. J. Biol. Chem. 269, 1\u20134 (1994).","journal-title":"J. Biol. Chem."},{"key":"1862_CR29","doi-asserted-by":"publisher","first-page":"10350","DOI":"10.1073\/pnas.89.21.10350","volume":"89","author":"MG Myers Jr.","year":"1992","unstructured":"Myers, M. G. Jr. et al. IRS-1 activates phosphatidylinositol 3\u2019-kinase by associating with src homology 2 domains of p85. Proc. Natl. Acad. Sci. USA. 89, 10350\u201310354 https:\/\/doi.org\/10.1073\/pnas.89.21.10350 (1992).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"1862_CR30","doi-asserted-by":"publisher","first-page":"5748","DOI":"10.1016\/S0021-9258(18)53382-2","volume":"268","author":"GJ Pronk","year":"1993","unstructured":"Pronk, G. J., McGlade, J., Pelicci, G., Pawson, T. & Bos, J. L. Insulin-induced phosphorylation of the 46- and 52-kDa Shc proteins. J. Biol. Chem. 268, 5748\u20135753 (1993).","journal-title":"J. Biol. Chem."},{"key":"1862_CR31","doi-asserted-by":"publisher","first-page":"13689","DOI":"10.1016\/S0021-9258(17)36885-0","volume":"269","author":"T Sasaoka","year":"1994","unstructured":"Sasaoka, T. et al. Evidence for a functional role of Shc proteins in mitogenic signaling induced by insulin, insulin-like growth factor-1, and epidermal growth factor. J. Biol. Chem. 269, 13689\u201313694 (1994).","journal-title":"J. Biol. Chem."},{"key":"1862_CR32","doi-asserted-by":"publisher","first-page":"10734","DOI":"10.1016\/S0021-9258(17)34120-0","volume":"269","author":"T Sasaoka","year":"1994","unstructured":"Sasaoka, T., Draznin, B., Leitner, J. W., Langlois, W. J. & Olefsky, J. M. Shc is the predominant signaling molecule coupling insulin receptors to activation of guanine nucleotide releasing factor and p21ras-GTP formation. J. Biol. Chem. 269, 10734\u201310738 (1994).","journal-title":"J. Biol. Chem."},{"key":"1862_CR33","doi-asserted-by":"publisher","first-page":"31107","DOI":"10.1016\/S0021-9258(18)47396-6","volume":"269","author":"K Yamauchi","year":"1994","unstructured":"Yamauchi, K. & Pessin, J. E. Insulin receptor substrate-1 (IRS1) and Shc compete for a limited pool of Grb2 in mediating insulin downstream signaling. J. Biol. Chem. 269, 31107\u201331114 (1994).","journal-title":"J. Biol. Chem."},{"key":"1862_CR34","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.molmet.2016.02.004","volume":"5","author":"S Hausmann","year":"2016","unstructured":"Hausmann, S. & Ussar, S. Insulin receptor trafficking steers insulin action. Mol. Metab. 5, 253\u2013254 https:\/\/doi.org\/10.1016\/j.molmet.2016.02.004 (2016).","journal-title":"Mol. Metab."},{"key":"1862_CR35","doi-asserted-by":"publisher","first-page":"17615","DOI":"10.1073\/pnas.0906541106","volume":"106","author":"JE Murphy","year":"2009","unstructured":"Murphy, J. E., Padilla, B. E., Hasdemir, B., Cottrell, G. S. & Bunnett, N. W. Endosomes: a legitimate platform for the signaling train. Proc. Natl. Acad. Sci. USA 106, 17615\u201317622 https:\/\/doi.org\/10.1073\/pnas.0906541106 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1862_CR36","doi-asserted-by":"publisher","first-page":"4106","DOI":"10.1016\/j.cell.2025.05.005","volume":"188","author":"J Kjaergaard","year":"2025","unstructured":"Kjaergaard, J. et al. Personalized molecular signatures of insulin resistance and type 2 diabetes. Cell 188, 4106\u20134122.e4116 https:\/\/doi.org\/10.1016\/j.cell.2025.05.005 (2025).","journal-title":"Cell"},{"key":"1862_CR37","doi-asserted-by":"publisher","first-page":"14101","DOI":"10.1074\/jbc.M110.110536","volume":"285","author":"HA Walz","year":"2010","unstructured":"Walz, H. A. et al. Isoform-specific regulation of Akt signaling by the endosomal protein WDFY2. J. Biol. Chem. 285, 14101\u201314108 https:\/\/doi.org\/10.1074\/jbc.M110.110536 (2010).","journal-title":"J. Biol. Chem."},{"key":"1862_CR38","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.2337\/db23-0314","volume":"72","author":"J Park","year":"2023","unstructured":"Park, J. et al. MAD2-dependent insulin receptor endocytosis regulates metabolic homeostasis. Diabetes 72, 1781\u20131794 https:\/\/doi.org\/10.2337\/db23-0314 (2023).","journal-title":"Diabetes"},{"key":"1862_CR39","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.cell.2016.05.074","volume":"166","author":"E Choi","year":"2016","unstructured":"Choi, E., Zhang, X., Xing, C. & Yu, H. Mitotic checkpoint regulators control insulin signaling and metabolic homeostasis. Cell 166, 567\u2013581 https:\/\/doi.org\/10.1016\/j.cell.2016.05.074 (2016).","journal-title":"Cell"},{"key":"1862_CR40","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1038\/s42255-022-00634-5","volume":"4","author":"X Liu","year":"2022","unstructured":"Liu, X. et al. Insulin induces insulin receptor degradation in the liver through EphB4. Nat. Metab. 4, 1202\u20131213 https:\/\/doi.org\/10.1038\/s42255-022-00634-5 (2022).","journal-title":"Nat. Metab."},{"key":"1862_CR41","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/s41586-021-03225-8","volume":"590","author":"Ansarullah","year":"2021","unstructured":"Ansarullah et al. Inceptor counteracts insulin signalling in beta-cells to control glycaemia. Nature 590, 326\u2013331 https:\/\/doi.org\/10.1038\/s41586-021-03225-8 (2021).","journal-title":"Nature"},{"key":"1862_CR42","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1096\/fasebj.13.14.1961","volume":"13","author":"J Gustavsson","year":"1999","unstructured":"Gustavsson, J. et al. Localization of the insulin receptor in caveolae of adipocyte plasma membrane. FASEB J. 13, 1961\u20131971 (1999).","journal-title":"FASEB J."},{"key":"1862_CR43","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/jss.400060104","volume":"6","author":"L Jarett","year":"1977","unstructured":"Jarett, L. & Smith, R. M. The natural occurrence of insulin receptors in groups on adipocyte plasma membranes as demonstrated with monomeric ferritin-insulin. J. Supramol. Struct. 6, 45\u201359 https:\/\/doi.org\/10.1002\/jss.400060104 (1977).","journal-title":"J. Supramol. Struct."},{"key":"1862_CR44","doi-asserted-by":"publisher","first-page":"7747","DOI":"10.1039\/d2nr01051h","volume":"14","author":"H Li","year":"2022","unstructured":"Li, H. et al. Mechanism of INSR clustering with insulin activation and resistance revealed by super-resolution imaging. Nanoscale 14, 7747\u20137755 https:\/\/doi.org\/10.1039\/d2nr01051h (2022).","journal-title":"Nanoscale"},{"key":"1862_CR45","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/s41565-023-01507-y","volume":"19","author":"J Spratt","year":"2024","unstructured":"Spratt, J. et al. Multivalent insulin receptor activation using insulin-DNA origami nanostructures. Nat. Nanotechnol. 19, 237\u2013245 https:\/\/doi.org\/10.1038\/s41565-023-01507-y (2024).","journal-title":"Nat. Nanotechnol."},{"key":"1862_CR46","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1172\/JCI5971","volume":"104","author":"ZY Jiang","year":"1999","unstructured":"Jiang, Z. Y. et al. Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa\/fa) rats. J. Clin. Invest 104, 447\u2013457 https:\/\/doi.org\/10.1172\/JCI5971 (1999).","journal-title":"J. Clin. Invest"},{"key":"1862_CR47","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.molcel.2012.04.018","volume":"46","author":"H Kubota","year":"2012","unstructured":"Kubota, H. et al. Temporal coding of insulin action through multiplexing of the AKT pathway. Mol. Cell 46, 820\u2013832 https:\/\/doi.org\/10.1016\/j.molcel.2012.04.018 (2012).","journal-title":"Mol. Cell"},{"key":"1862_CR48","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.2337\/db11-1462","volume":"61","author":"AV Matveyenko","year":"2012","unstructured":"Matveyenko, A. V. et al. Pulsatile portal vein insulin delivery enhances hepatic insulin action and signaling. Diabetes 61, 2269\u20132279 https:\/\/doi.org\/10.2337\/db11-1462 (2012).","journal-title":"Diabetes"},{"key":"1862_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2022.167458","volume":"434","author":"J Nielsen","year":"2022","unstructured":"Nielsen, J. et al. Structural investigations of full-length insulin receptor dynamics and signalling. J. Mol. Biol. 434, 167458 https:\/\/doi.org\/10.1016\/j.jmb.2022.167458 (2022).","journal-title":"J. Mol. Biol."},{"key":"1862_CR50","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/s41594-022-00750-6","volume":"29","author":"J Li","year":"2022","unstructured":"Li, J. et al. Synergistic activation of the insulin receptor via two distinct sites. Nat. Struct. Mol. Biol. 29, 357\u2013368 https:\/\/doi.org\/10.1038\/s41594-022-00750-6 (2022).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"1862_CR51","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.peptides.2017.11.022","volume":"100","author":"SJ Brandt","year":"2018","unstructured":"Brandt, S. J., Mayer, J. P., Ford, J., Gelfanov, V. M. & DiMarchi, R. D. Controlled intramolecular antagonism as a regulator of insulin receptor maximal activity. Peptides 100, 18\u201323 https:\/\/doi.org\/10.1016\/j.peptides.2017.11.022 (2018).","journal-title":"Peptides"},{"key":"1862_CR52","doi-asserted-by":"publisher","first-page":"35179","DOI":"10.1074\/jbc.M704599200","volume":"282","author":"M Jensen","year":"2007","unstructured":"Jensen, M., Hansen, B., De Meyts, P., Schaffer, L. & Urso, B. Activation of the insulin receptor by insulin and a synthetic peptide leads to divergent metabolic and mitogenic signaling and responses. J. Biol. Chem. 282, 35179\u201335186 https:\/\/doi.org\/10.1074\/jbc.M704599200 (2007).","journal-title":"J. Biol. Chem."},{"key":"1862_CR53","doi-asserted-by":"publisher","first-page":"22590","DOI":"10.1074\/jbc.M202119200","volume":"277","author":"RC Pillutla","year":"2002","unstructured":"Pillutla, R. C. et al. Peptides identify the critical hotspots involved in the biological activation of the insulin receptor. J. Biol. Chem. 277, 22590\u201322594 https:\/\/doi.org\/10.1074\/jbc.M202119200 (2002).","journal-title":"J. Biol. Chem."},{"key":"1862_CR54","doi-asserted-by":"publisher","first-page":"4435","DOI":"10.1073\/pnas.0830026100","volume":"100","author":"L Schaffer","year":"2003","unstructured":"Schaffer, L. et al. Assembly of high-affinity insulin receptor agonists and antagonists from peptide building blocks. Proc. Natl. Acad. Sci. USA 100, 4435\u20134439 https:\/\/doi.org\/10.1073\/pnas.0830026100 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1862_CR55","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.2337\/db14-0914","volume":"64","author":"H Frikke-Schmidt","year":"2015","unstructured":"Frikke-Schmidt, H. et al. Treatment of diabetic rats with insulin or a synthetic insulin receptor agonist peptide leads to divergent metabolic responses. Diabetes 64, 1057\u20131066 https:\/\/doi.org\/10.2337\/db14-0914 (2015).","journal-title":"Diabetes"},{"key":"1862_CR56","doi-asserted-by":"publisher","first-page":"946","DOI":"10.2337\/db17-0744","volume":"67","author":"JE Kanter","year":"2018","unstructured":"Kanter, J. E. et al. A novel strategy to prevent advanced atherosclerosis and lower blood glucose in a mouse model of metabolic syndrome. Diabetes 67, 946\u2013959 https:\/\/doi.org\/10.2337\/db17-0744 (2018).","journal-title":"Diabetes"},{"key":"1862_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33274-0","volume":"13","author":"J Park","year":"2022","unstructured":"Park, J. et al. Activation of the insulin receptor by an insulin mimetic peptide. Nat. Commun. 13, 5594 https:\/\/doi.org\/10.1038\/s41467-022-33274-0 (2022).","journal-title":"Nat. Commun."},{"key":"1862_CR58","doi-asserted-by":"publisher","first-page":"15473","DOI":"10.1074\/jbc.M116.732180","volume":"291","author":"CF Lawrence","year":"2016","unstructured":"Lawrence, C. F. et al. Insulin mimetic peptide disrupts the primary binding site of the insulin receptor. J. Biol. Chem. 291, 15473\u201315481 https:\/\/doi.org\/10.1074\/jbc.M116.732180 (2016).","journal-title":"J. Biol. Chem."},{"key":"1862_CR59","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.bbrc.2008.08.151","volume":"376","author":"L Schaffer","year":"2008","unstructured":"Schaffer, L. et al. A novel high-affinity peptide antagonist to the insulin receptor. Biochem Biophys. Res Commun. 376, 380\u2013383 https:\/\/doi.org\/10.1016\/j.bbrc.2008.08.151 (2008).","journal-title":"Biochem Biophys. Res Commun."},{"key":"1862_CR60","doi-asserted-by":"publisher","unstructured":"Pol\u00e1k, M. et al. Antagonistic insulin mimetics lock the insulin receptor in an alternative apo-state. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2025.08.05.667158 (2025).","DOI":"10.1101\/2025.08.05.667158"},{"key":"1862_CR61","doi-asserted-by":"publisher","first-page":"4064","DOI":"10.1016\/j.molcel.2025.09.020","volume":"85","author":"X Wang","year":"2025","unstructured":"Wang, X. et al. Tuning insulin receptor signaling using de novo-designed agonists. Mol. Cell 85, 4064\u20134081.e4069 https:\/\/doi.org\/10.1016\/j.molcel.2025.09.020 (2025).","journal-title":"Mol. Cell"},{"key":"1862_CR62","doi-asserted-by":"publisher","first-page":"7516","DOI":"10.1021\/acs.jmedchem.3c00280","volume":"66","author":"C Park","year":"2023","unstructured":"Park, C. et al. Antagonistic insulin derivative suppresses insulin-induced hypoglycemia. J. Med Chem. 66, 7516\u20137522 https:\/\/doi.org\/10.1021\/acs.jmedchem.3c00280 (2023).","journal-title":"J. Med Chem."},{"key":"1862_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-026-73851-1","volume":"17","author":"A Vogel","year":"2026","unstructured":"Vogel, A. et al. Structural basis of insulin receptor antagonism by bivalent site 1-site 2 ligands S961 and Ins-AC-S2. Nat. Commun. 17, 5068 https:\/\/doi.org\/10.1038\/s41467-026-73851-1 (2026).","journal-title":"Nat. Commun."},{"key":"1862_CR64","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/s41586-022-04654-9","volume":"605","author":"L Cao","year":"2022","unstructured":"Cao, L. et al. Design of protein-binding proteins from the target structure alone. Nature 605, 551\u2013560 https:\/\/doi.org\/10.1038\/s41586-022-04654-9 (2022).","journal-title":"Nature"},{"key":"1862_CR65","doi-asserted-by":"publisher","first-page":"4111","DOI":"10.1016\/j.molcel.2025.10.032","volume":"85","author":"MF White","year":"2025","unstructured":"White, M. F. A new horizon unfolding for insulin signaling in health and disease. Mol. Cell 85, 4111\u20134113 https:\/\/doi.org\/10.1016\/j.molcel.2025.10.032 (2025).","journal-title":"Mol. Cell"},{"key":"1862_CR66","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1093\/nar\/gkaa1247","volume":"49","author":"NO Yunn","year":"2021","unstructured":"Yunn, N. O. et al. A hotspot for enhancing insulin receptor activation revealed by a conformation-specific allosteric aptamer. Nucleic Acids Res. 49, 700\u2013712 https:\/\/doi.org\/10.1093\/nar\/gkaa1247 (2021).","journal-title":"Nucleic Acids Res."},{"key":"1862_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34292-8","volume":"13","author":"J Kim","year":"2022","unstructured":"Kim, J. et al. Functional selectivity of insulin receptor revealed by aptamer-trapped receptor structures. Nat. Commun. 13, 6500 https:\/\/doi.org\/10.1038\/s41467-022-34292-8 (2022).","journal-title":"Nat. Commun."},{"key":"1862_CR68","doi-asserted-by":"publisher","first-page":"198","DOI":"10.2174\/1573399816666200604122345","volume":"17","author":"A Ashraf","year":"2021","unstructured":"Ashraf, A., Palakkott, A. & Ayoub, M. A. Anti-insulin receptor antibodies in the pathology and therapy of diabetes mellitus. Curr. Diab. Rev. 17, 198\u2013206 https:\/\/doi.org\/10.2174\/1573399816666200604122345 (2021).","journal-title":"Curr. Diab. Rev."},{"key":"1862_CR69","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1042\/bj2350199","volume":"235","author":"MA Soos","year":"1986","unstructured":"Soos, M. A. et al. Monoclonal antibodies reacting with multiple epitopes on the human insulin receptor. Biochem J. 235, 199\u2013208 https:\/\/doi.org\/10.1042\/bj2350199 (1986).","journal-title":"Biochem J."},{"key":"1862_CR70","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1177\/1932296814529886","volume":"8","author":"H Issafras","year":"2014","unstructured":"Issafras, H. et al. Selective allosteric antibodies to the insulin receptor for the treatment of hyperglycemic and hypoglycemic disorders. J. Diab. Sci. Technol. 8, 865\u2013873 https:\/\/doi.org\/10.1177\/1932296814529886 (2014).","journal-title":"J. Diab. Sci. Technol."},{"key":"1862_CR71","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1007\/s00125-018-4606-2","volume":"61","author":"GV Brierley","year":"2018","unstructured":"Brierley, G. V., Siddle, K. & Semple, R. K. Evaluation of anti-insulin receptor antibodies as potential novel therapies for human insulin receptoropathy using cell culture models. Diabetologia 61, 1662\u20131675 https:\/\/doi.org\/10.1007\/s00125-018-4606-2 (2018).","journal-title":"Diabetologia"},{"key":"1862_CR72","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.2337\/db20-0345","volume":"69","author":"GV Brierley","year":"2020","unstructured":"Brierley, G. V. et al. Anti-insulin receptor antibodies improve hyperglycemia in a mouse model of human insulin receptoropathy. Diabetes 69, 2481\u20132489 https:\/\/doi.org\/10.2337\/db20-0345 (2020).","journal-title":"Diabetes"},{"key":"1862_CR73","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.2337\/db11-1578","volume":"61","author":"V Bhaskar","year":"2012","unstructured":"Bhaskar, V. et al. A fully human, allosteric monoclonal antibody that activates the insulin receptor and improves glycemic control. Diabetes 61, 1263\u20131271 https:\/\/doi.org\/10.2337\/db11-1578 (2012).","journal-title":"Diabetes"},{"key":"1862_CR74","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1002\/jcb.25168","volume":"116","author":"DH Bedinger","year":"2015","unstructured":"Bedinger, D. H., Kieffer, D. A., Goldfine, I. D., Roell, M. K. & Adams, S. H. Acute treatment with XMetA activates hepatic insulin receptors and lowers blood glucose in normal mice. J. Cell Biochem 116, 2109\u20132119 https:\/\/doi.org\/10.1002\/jcb.25168 (2015).","journal-title":"J. Cell Biochem"},{"key":"1862_CR75","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1124\/jpet.115.229690","volume":"356","author":"P Bezwada","year":"2016","unstructured":"Bezwada, P. et al. A novel allosteric insulin receptor-activating antibody reduces hyperglycemia without hypoglycemia in diabetic cynomolgus monkeys. J. Pharm. Exp. Ther. 356, 466\u2013473 https:\/\/doi.org\/10.1124\/jpet.115.229690 (2016).","journal-title":"J. Pharm. Exp. Ther."},{"key":"1862_CR76","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0088684","volume":"9","author":"JA Corbin","year":"2014","unstructured":"Corbin, J. A. et al. Improved glucose metabolism in vitro and in vivo by an allosteric monoclonal antibody that increases insulin receptor binding affinity. PLoS One 9, e88684 https:\/\/doi.org\/10.1371\/journal.pone.0088684 (2014).","journal-title":"PLoS One"},{"key":"1862_CR77","doi-asserted-by":"publisher","first-page":"262","DOI":"10.4161\/mabs.26871","volume":"6","author":"JA Corbin","year":"2014","unstructured":"Corbin, J. A. et al. Inhibition of insulin receptor function by a human, allosteric monoclonal antibody: a potential new approach for the treatment of hyperinsulinemic hypoglycemia. MAbs 6, 262\u2013272 https:\/\/doi.org\/10.4161\/mabs.26871 (2014).","journal-title":"MAbs"},{"key":"1862_CR78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0031-6997(24)01433-9","volume":"52","author":"Z Vajo","year":"2000","unstructured":"Vajo, Z. & Duckworth, W. C. Genetically engineered insulin analogs: diabetes in the new millenium. Pharm. Rev. 52, 1\u20139 (2000).","journal-title":"Pharm. Rev."},{"key":"1862_CR79","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/nrd.2015.36","volume":"15","author":"AN Zaykov","year":"2016","unstructured":"Zaykov, A. N., Mayer, J. P. & DiMarchi, R. D. Pursuit of a perfect insulin. Nat. Rev. Drug Discov. 15, 425\u2013439 https:\/\/doi.org\/10.1038\/nrd.2015.36 (2016).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1862_CR80","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1038\/s41591-021-01418-2","volume":"27","author":"EK Sims","year":"2021","unstructured":"Sims, E. K., Carr, A. L. J., Oram, R. A., DiMeglio, L. A. & Evans-Molina, C. 100 years of insulin: celebrating the past, present and future of diabetes therapy. Nat. Med 27, 1154\u20131164 https:\/\/doi.org\/10.1038\/s41591-021-01418-2 (2021).","journal-title":"Nat. Med"},{"key":"1862_CR81","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/S2213-8587(21)00182-0","volume":"9","author":"PD Home","year":"2021","unstructured":"Home, P. D. & Mehta, R. Insulin therapy development beyond 100 years. Lancet Diab. Endocrinol. 9, 695\u2013707 https:\/\/doi.org\/10.1016\/S2213-8587(21)00182-0 (2021).","journal-title":"Lancet Diab. Endocrinol."},{"key":"1862_CR82","first-page":"97","volume":"9","author":"LL Madison","year":"1960","unstructured":"Madison, L. L., Uger, R. H. & Rencz, K. The physiologic significance of secretion of insulin into portal circulation: II. Effect of rate of administration of glucagon-free insulin on magnitude of peripheral and hepatic actions. Metabolism 9, 97\u2013108 (1960).","journal-title":"Metabolism"},{"key":"1862_CR83","doi-asserted-by":"publisher","first-page":"E891","DOI":"10.1152\/ajpendo.00628.2020","volume":"320","author":"DS Edgerton","year":"2021","unstructured":"Edgerton, D. S., Moore, M. C., Gregory, J. M., Kraft, G. & Cherrington, A. D. Importance of the route of insulin delivery to its control of glucose metabolism. Am. J. Physiol. Endocrinol. Metab. 320, E891\u2013E897 https:\/\/doi.org\/10.1152\/ajpendo.00628.2020 (2021).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"1862_CR84","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/s41392-022-01073-0","volume":"7","author":"M Li","year":"2022","unstructured":"Li, M. et al. Trends in insulin resistance: insights into mechanisms and therapeutic strategy. Signal Transduct. Target Ther. 7, 216 https:\/\/doi.org\/10.1038\/s41392-022-01073-0 (2022).","journal-title":"Signal Transduct. Target Ther."},{"key":"1862_CR85","unstructured":"Mesika, A., Klar, A. & Falik Zaccai, T. C. in GeneReviews((R)) (eds M. P. Adam et al.) (1993)."},{"key":"1862_CR86","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1210\/jcem.79.3.8077364","volume":"79","author":"N Longo","year":"1994","unstructured":"Longo, N. et al. Impaired growth in Rabson-Mendenhall syndrome: lack of effect of growth hormone and insulin-like growth factor-I. J. Clin. Endocrinol. Metab. 79, 799\u2013805 https:\/\/doi.org\/10.1210\/jcem.79.3.8077364 (1994).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1862_CR87","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1677\/joe.0.1410177","volume":"141","author":"JD Quin","year":"1994","unstructured":"Quin, J. D. et al. Response of insulin-like growth factor (IGF)-binding protein-1 (IGFBP-1) and IGFBP-3 to IGF-I treatment in severe insulin resistance. J. Endocrinol. 141, 177\u2013182 https:\/\/doi.org\/10.1677\/joe.0.1410177 (1994).","journal-title":"J. Endocrinol."},{"key":"1862_CR88","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1056\/NEJM199011153232016","volume":"323","author":"JD Quin","year":"1990","unstructured":"Quin, J. D. et al. Acute response to recombinant insulin-like growth factor I in a patient with Mendenhall\u2019s syndrome. N. Engl. J. Med. 323, 1425\u20131426 https:\/\/doi.org\/10.1056\/NEJM199011153232016 (1990).","journal-title":"N. Engl. J. Med."},{"key":"1862_CR89","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/j.1365-2265.2010.03810.x","volume":"73","author":"RK Semple","year":"2010","unstructured":"Semple, R. K., Williams, R. M. & Dunger, D. B. What is the best management strategy for patients with severe insulin resistance? Clin. Endocrinol. (Oxf.) 73, 286\u2013290 https:\/\/doi.org\/10.1111\/j.1365-2265.2010.03810.x (2010).","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"1862_CR90","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1080\/13813450801954451","volume":"114","author":"P Pisani","year":"2008","unstructured":"Pisani, P. Hyper-insulinaemia and cancer, meta-analyses of epidemiological studies. Arch. Physiol. Biochem 114, 63\u201370 https:\/\/doi.org\/10.1080\/13813450801954451 (2008).","journal-title":"Arch. Physiol. Biochem"},{"key":"1862_CR91","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/nrc2536","volume":"8","author":"M Pollak","year":"2008","unstructured":"Pollak, M. Insulin and insulin-like growth factor signalling in neoplasia. Nat. Rev. Cancer 8, 915\u2013928 https:\/\/doi.org\/10.1038\/nrc2536 (2008).","journal-title":"Nat. Rev. Cancer"},{"key":"1862_CR92","doi-asserted-by":"publisher","first-page":"6349","DOI":"10.7314\/apjcp.2014.15.15.6349","volume":"15","author":"F Pan","year":"2014","unstructured":"Pan, F. & Hong, L. Q. Insulin promotes proliferation and migration of breast cancer cells through the extracellular regulated kinase pathway. Asian Pac. J. Cancer Prev. 15, 6349\u20136352 https:\/\/doi.org\/10.7314\/apjcp.2014.15.15.6349 (2014).","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"1862_CR93","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.685059","volume":"11","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y. et al. Oleic acid and insulin as key characteristics of T2D promote colorectal cancer deterioration in xenograft mice revealed by functional metabolomics. Front Oncol. 11, 685059 https:\/\/doi.org\/10.3389\/fonc.2021.685059 (2021).","journal-title":"Front Oncol."},{"key":"1862_CR94","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.celrep.2018.06.008","volume":"24","author":"Y Wang","year":"2018","unstructured":"Wang, Y. et al. Uncoupling hepatic oxidative phosphorylation reduces tumor growth in two murine models of colon cancer. Cell Rep. 24, 47\u201355 https:\/\/doi.org\/10.1016\/j.celrep.2018.06.008 (2018).","journal-title":"Cell Rep."},{"key":"1862_CR95","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.canlet.2012.03.026","volume":"322","author":"Y Wang","year":"2012","unstructured":"Wang, Y. et al. Insulin promotes proliferation, survival, and invasion in endometrial carcinoma by activating the MEK\/ERK pathway. Cancer Lett. 322, 223\u2013231 https:\/\/doi.org\/10.1016\/j.canlet.2012.03.026 (2012).","journal-title":"Cancer Lett."},{"key":"1862_CR96","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.tem.2010.06.007","volume":"21","author":"EJ Gallagher","year":"2010","unstructured":"Gallagher, E. J. & LeRoith, D. The proliferating role of insulin and insulin-like growth factors in cancer. Trends Endocrinol. Metab. 21, 610\u2013618 https:\/\/doi.org\/10.1016\/j.tem.2010.06.007 (2010).","journal-title":"Trends Endocrinol. Metab."},{"key":"1862_CR97","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1007\/s40618-016-0508-7","volume":"39","author":"R Vigneri","year":"2016","unstructured":"Vigneri, R., Goldfine, I. D. & Frittitta, L. Insulin, insulin receptors, and cancer. J. Endocrinol. Invest 39, 1365\u20131376 https:\/\/doi.org\/10.1007\/s40618-016-0508-7 (2016).","journal-title":"J. Endocrinol. Invest"},{"key":"1862_CR98","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/(sici)1098-2744(199701)18:1<19::aid-mc3>3.0.co;2-m","volume":"18","author":"G Milazzo","year":"1997","unstructured":"Milazzo, G., Sciacca, L., Papa, V., Goldfine, I. D. & Vigneri, R. ASPB10 insulin induction of increased mitogenic responses and phenotypic changes in human breast epithelial cells: evidence for enhanced interactions with the insulin-like growth factor-I receptor. Mol. Carcinog. 18, 19\u201325 https:\/\/doi.org\/10.1002\/(sici)1098-2744(199701)18:1<19::aid-mc3>3.0.co;2-m (1997).","journal-title":"Mol. Carcinog."},{"key":"1862_CR99","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1530\/ERC-12-0125","volume":"19","author":"H Hvid","year":"2012","unstructured":"Hvid, H. et al. Stimulation of MC38 tumor growth by insulin analog X10 involves the serine synthesis pathway. Endocr. Relat. Cancer 19, 557\u2013574 https:\/\/doi.org\/10.1530\/ERC-12-0125 (2012).","journal-title":"Endocr. Relat. Cancer"},{"key":"1862_CR100","doi-asserted-by":"publisher","first-page":"e79710","DOI":"10.1371\/journal.pone.0079710","volume":"8","author":"H Hvid","year":"2013","unstructured":"Hvid, H. et al. Treatment with insulin analog X10 and IGF-1 increases growth of colon cancer allografts. PLoS One 8, e79710 https:\/\/doi.org\/10.1371\/journal.pone.0079710 (2013).","journal-title":"PLoS One"},{"key":"1862_CR101","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46990-6","volume":"15","author":"W An","year":"2024","unstructured":"An, W. et al. Activation of the insulin receptor by insulin-like growth factor 2. Nat. Commun. 15, 2609 https:\/\/doi.org\/10.1038\/s41467-024-46990-6 (2024).","journal-title":"Nat. Commun."},{"key":"1862_CR102","doi-asserted-by":"publisher","first-page":"R125","DOI":"10.1530\/ERC-11-0074","volume":"18","author":"A Belfiore","year":"2011","unstructured":"Belfiore, A. & Malaguarnera, R. Insulin receptor and cancer. Endocr. Relat. Cancer 18, R125\u2013R147 https:\/\/doi.org\/10.1530\/ERC-11-0074 (2011).","journal-title":"Endocr. Relat. Cancer"},{"key":"1862_CR103","doi-asserted-by":"publisher","first-page":"3278","DOI":"10.1128\/MCB.19.5.3278","volume":"19","author":"F Frasca","year":"1999","unstructured":"Frasca, F. et al. Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells. Mol. Cell Biol. 19, 3278\u20133288 https:\/\/doi.org\/10.1128\/MCB.19.5.3278 (1999).","journal-title":"Mol. Cell Biol."},{"key":"1862_CR104","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1210\/jcem.87.1.8142","volume":"87","author":"V Vella","year":"2002","unstructured":"Vella, V. et al. A novel autocrine loop involving IGF-II and the insulin receptor isoform-A stimulates growth of thyroid cancer. J. Clin. Endocrinol. Metab. 87, 245\u2013254 https:\/\/doi.org\/10.1210\/jcem.87.1.8142 (2002).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1862_CR105","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1093\/humrep\/dew243","volume":"31","author":"S Cassar","year":"2016","unstructured":"Cassar, S. et al. Insulin resistance in polycystic ovary syndrome: a systematic review and meta-analysis of euglycaemic-hyperinsulinaemic clamp studies. Hum. Reprod. 31, 2619\u20132631 https:\/\/doi.org\/10.1093\/humrep\/dew243 (2016).","journal-title":"Hum. Reprod."},{"key":"1862_CR106","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/719050","volume":"2014","author":"J Rojas","year":"2014","unstructured":"Rojas, J. et al. Polycystic ovary syndrome, insulin resistance, and obesity: navigating the pathophysiologic labyrinth. Int J. Reprod. Med. 2014, 719050 https:\/\/doi.org\/10.1155\/2014\/719050 (2014).","journal-title":"Int J. Reprod. Med."},{"key":"1862_CR107","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1210\/edrv.18.6.0318","volume":"18","author":"A Dunaif","year":"1997","unstructured":"Dunaif, A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr. Rev. 18, 774\u2013800 https:\/\/doi.org\/10.1210\/edrv.18.6.0318 (1997).","journal-title":"Endocr. Rev."},{"key":"1862_CR108","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.2337\/diab.41.10.1257","volume":"41","author":"A Dunaif","year":"1992","unstructured":"Dunaif, A. et al. Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome. Diabetes 41, 1257\u20131266 https:\/\/doi.org\/10.2337\/diab.41.10.1257 (1992).","journal-title":"Diabetes"},{"key":"1862_CR109","doi-asserted-by":"publisher","first-page":"3110","DOI":"10.1210\/jcem.84.9.6010","volume":"84","author":"CB Book","year":"1999","unstructured":"Book, C. B. & Dunaif, A. Selective insulin resistance in the polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 84, 3110\u20133116 https:\/\/doi.org\/10.1210\/jcem.84.9.6010 (1999).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1862_CR110","doi-asserted-by":"publisher","first-page":"E1047","DOI":"10.1152\/ajpendo.00361.2004","volume":"288","author":"A Corbould","year":"2005","unstructured":"Corbould, A. et al. Insulin resistance in the skeletal muscle of women with PCOS involves intrinsic and acquired defects in insulin signaling. Am. J. Physiol. Endocrinol. Metab. 288, E1047\u2013E1054 https:\/\/doi.org\/10.1152\/ajpendo.00361.2004 (2005).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"1862_CR111","doi-asserted-by":"publisher","first-page":"E392","DOI":"10.1152\/ajpendo.2001.281.2.E392","volume":"281","author":"A Dunaif","year":"2001","unstructured":"Dunaif, A., Wu, X., Lee, A. & Diamanti-Kandarakis, E. Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS). Am. J. Physiol. Endocrinol. Metab. 281, E392\u2013E399 https:\/\/doi.org\/10.1152\/ajpendo.2001.281.2.E392 (2001).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"1862_CR112","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/s0015-0282(00)00688-9","volume":"74","author":"X Wu","year":"2000","unstructured":"Wu, X. et al. Expression of insulin-receptor substrate-1 and -2 in ovaries from women with insulin resistance and from controls. Fertil. Steril. 74, 564\u2013572 https:\/\/doi.org\/10.1016\/s0015-0282(00)00688-9 (2000).","journal-title":"Fertil. Steril."},{"key":"1862_CR113","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/s0015-0282(03)01007-0","volume":"80","author":"XK Wu","year":"2003","unstructured":"Wu, X. K. et al. Selective ovary resistance to insulin signaling in women with polycystic ovary syndrome. Fertil. Steril. 80, 954\u2013965 https:\/\/doi.org\/10.1016\/s0015-0282(03)01007-0 (2003).","journal-title":"Fertil. Steril."},{"key":"1862_CR114","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1093\/molehr\/gah066","volume":"10","author":"HW Yen","year":"2004","unstructured":"Yen, H. W., Jakimiuk, A. J., Munir, I. & Magoffin, D. A. Selective alterations in insulin receptor substrates-1, -2 and -4 in theca but not granulosa cells from polycystic ovaries. Mol. Hum. Reprod. 10, 473\u2013479 https:\/\/doi.org\/10.1093\/molehr\/gah066 (2004).","journal-title":"Mol. Hum. Reprod."},{"key":"1862_CR115","doi-asserted-by":"publisher","first-page":"623","DOI":"10.4049\/jimmunol.1302181","volume":"192","author":"JM Han","year":"2014","unstructured":"Han, J. M., Patterson, S. J., Speck, M., Ehses, J. A. & Levings, M. K. Insulin inhibits IL-10-mediated regulatory T cell function: implications for obesity. J. Immunol. 192, 623\u2013629 https:\/\/doi.org\/10.4049\/jimmunol.1302181 (2014).","journal-title":"J. Immunol."},{"key":"1862_CR116","doi-asserted-by":"publisher","first-page":"e1000938","DOI":"10.1371\/journal.pgen.1000938","volume":"6","author":"J Mauer","year":"2010","unstructured":"Mauer, J. et al. Myeloid cell-restricted insulin receptor deficiency protects against obesity-induced inflammation and systemic insulin resistance. PLoS Genet 6, e1000938 https:\/\/doi.org\/10.1371\/journal.pgen.1000938 (2010).","journal-title":"PLoS Genet"},{"key":"1862_CR117","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.cmet.2018.08.003","volume":"28","author":"S Tsai","year":"2018","unstructured":"Tsai, S. et al. Insulin receptor-mediated stimulation boosts T cell immunity during inflammation and infection. Cell Metab. 28, 922\u2013934.e924 https:\/\/doi.org\/10.1016\/j.cmet.2018.08.003 (2018).","journal-title":"Cell Metab."},{"key":"1862_CR118","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1210\/er.2017-00073","volume":"38","author":"A Belfiore","year":"2017","unstructured":"Belfiore, A. et al. Insulin receptor isoforms in physiology and disease: an updated view. Endocr. Rev. 38, 379\u2013431 https:\/\/doi.org\/10.1210\/er.2017-00073 (2017).","journal-title":"Endocr. Rev."},{"key":"1862_CR119","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2022.111739","volume":"557","author":"R Malaguarnera","year":"2022","unstructured":"Malaguarnera, R. et al. Comparative proteomic analysis of insulin receptor isoform A and B signaling. Mol. Cell Endocrinol. 557, 111739 https:\/\/doi.org\/10.1016\/j.mce.2022.111739 (2022).","journal-title":"Mol. Cell Endocrinol."},{"key":"1862_CR120","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.bcp.2013.12.012","volume":"88","author":"SM de la Monte","year":"2014","unstructured":"de la Monte, S. M. & Tong, M. Brain metabolic dysfunction at the core of Alzheimer\u2019s disease. Biochem Pharm. 88, 548\u2013559 https:\/\/doi.org\/10.1016\/j.bcp.2013.12.012 (2014).","journal-title":"Biochem Pharm."},{"key":"1862_CR121","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/S1474-4422(20)30231-3","volume":"19","author":"D Kellar","year":"2020","unstructured":"Kellar, D. & Craft, S. Brain insulin resistance in Alzheimer\u2019s disease and related disorders: mechanisms and therapeutic approaches. Lancet Neurol. 19, 758\u2013766 https:\/\/doi.org\/10.1016\/S1474-4422(20)30231-3 (2020).","journal-title":"Lancet Neurol."},{"key":"1862_CR122","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.neuron.2008.04.014","volume":"58","author":"SL Chiu","year":"2008","unstructured":"Chiu, S. L., Chen, C. M. & Cline, H. T. Insulin receptor signaling regulates synapse number, dendritic plasticity, and circuit function in vivo. Neuron 58, 708\u2013719 https:\/\/doi.org\/10.1016\/j.neuron.2008.04.014 (2008).","journal-title":"Neuron"},{"key":"1862_CR123","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1172\/JCI59903","volume":"122","author":"K Talbot","year":"2012","unstructured":"Talbot, K. et al. Demonstrated brain insulin resistance in Alzheimer\u2019s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J. Clin. Invest 122, 1316\u20131338 https:\/\/doi.org\/10.1172\/JCI59903 (2012).","journal-title":"J. Clin. Invest"},{"key":"1862_CR124","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1172\/JCI57256","volume":"122","author":"TR Bomfim","year":"2012","unstructured":"Bomfim, T. R. et al. An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer\u2019s disease- associated Abeta oligomers. J. Clin. Invest 122, 1339\u20131353 https:\/\/doi.org\/10.1172\/JCI57256 (2012).","journal-title":"J. Clin. Invest"},{"key":"1862_CR125","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.neuron.2017.09.003","volume":"96","author":"N Zhao","year":"2017","unstructured":"Zhao, N. et al. Apolipoprotein E4 impairs neuronal insulin signaling by trapping insulin receptor in the endosomes. Neuron 96, 115\u2013129.e115 https:\/\/doi.org\/10.1016\/j.neuron.2017.09.003 (2017).","journal-title":"Neuron"},{"key":"1862_CR126","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/jnc.14950","volume":"156","author":"M Gralle","year":"2021","unstructured":"Gralle, M., Labrecque, S., Salesse, C. & De Koninck, P. Spatial dynamics of the insulin receptor in living neurons. J. Neurochem 156, 88\u2013105 https:\/\/doi.org\/10.1111\/jnc.14950 (2021).","journal-title":"J. Neurochem"},{"key":"1862_CR127","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.addr.2018.07.009","volume":"130","author":"M Yu","year":"2018","unstructured":"Yu, M. et al. Battle of GLP-1 delivery technologies. Adv. Drug Deliv. Rev. 130, 113\u2013130 https:\/\/doi.org\/10.1016\/j.addr.2018.07.009 (2018).","journal-title":"Adv. Drug Deliv. Rev."}],"container-title":["Experimental &amp; Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01862-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01862-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01862-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T01:04:25Z","timestamp":1793840665000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01862-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,7]]},"references-count":127,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["1862"],"URL":"https:\/\/doi.org\/10.1038\/s12276-026-01862-5","relation":{},"ISSN":["2092-6413"],"issn-type":[{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,7]]},"assertion":[{"value":"15 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}